Jan B. Vermorken

发表

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.

M. Buyse, J. Pignon, T. Pajak, 2009, The Lancet. Oncology.

The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer

J. Vermorken, Jan B. Vermorken, 2001, International Journal of Gynecologic Cancer.

A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumors.

G. Giaccone, S. Linn, H. Pinedo, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study

J. Langendijk, G. Koutsodontis, É. Remenár, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions

R. Hitt, R. Haddad, E. Cohen, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.

G. Bonsel, P. Verboom, M. Groot, 2005, Vaccine.

From chemoprevention and organ preservation programmes to postoperative management: major achievements and strategies of the EORTC Head and Neck Cancer Group.

J. Bernier, C. Debruyne, H. Langendijk, 2012, European journal of cancer.

Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck.

T. Gauler, A. Dietz, O. Hamid, 2013, European journal of cancer.

Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.

H. Pinedo, J. Vermorken, W. van der Vijgh, 1987, Cancer research.

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).

D. Lacombe, J. Bogaerts, J. Bernier, 2008, European journal of cancer.

Expression of drug resistance proteins in breast cancer, in relation to chemotherapy

G. Giaccone, S. Linn, H. Pinedo, 1997, International journal of cancer.

Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study

J. Bogaerts, J. Bartlett, D. Cameron, 2017, Breast Cancer Research and Treatment.